Sai Life Sciences and Mabtech Announce Strategic Collaboration for Immunology Research with EYRA Platform at Sai Boston Site

Sai Life Sciences Ltd. has announced a strategic collaboration with Mabtech to establish Sai’s Boston laboratory as a co-marketed US execution and demonstration hub for the Mabtech EYRA™ platform. This collaboration aims to deliver advanced immunology assay services, including high-sensitivity multiplex cytokine and phenotyping workflows, powered by the EYRA platform installed at Sai’s Boston discovery site. This initiative accelerates access to next-generation immune profiling capabilities for biopharma and biotech companies working in immuno-oncology, vaccines, inflammation, and cellular therapy.